Community-led intervention curbs childhood obesity and boosts quality of life

The RESPOND trial adapted to COVID-19 disruptions by shifting to a cluster-parallel randomized design, enabling analysis despite the pandemic’s impact on school and community participation rates.

BioNTech reports net loss of €315.1m in Q1 2024

The decline in total revenue is attributed to reduced commercial revenues from the sales of the company’s Covid-19 vaccine. Credit: Seda Yalova/ Shutterstock.com. BioNTech has

May 7, 2024

Tempus AI expands oncology collaboration with Takeda

The collaboration aims to utilise Tempus’ real-world data and biological modelling to enhance the development of Takeda’s oncology treatment portfolio. Credit: Lightspring/ Shutterstock. Tempus AI

September 27, 2024

MarketingRx roundup: Genentech, Bristol Myers lead Fast Company innovators list; Real Chemistry inks AI deal

Genentech in the biotech category and Bristol Myers Squibb in the pharmaceutical category notched top spots on Fast Company’s annual best workplaces for innovators list

July 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.